Skip to main content

Your search for “Immune System” returned 447 results

Targeted Drug Delivery With These Nanoparticles Can Make Medicines More Effective

September 16, 2015

…healing power of drug treatments for cardiovascular disease and systemic bacterial infections. These nanoparticles are capable of delivering drugs to targeted sites in the body — particularly injured blood vessels and organs infected by harmful bacteria. This targeted drug delivery greatly increased the therapeutic effects of drugs administered to diseased…

Stem Cell Therapy Rescues Symptoms of Alzheimer’s Disease

August 9, 2023

Promising preclinical results from UC San Diego show hematopoietic stem cell therapy was effective in rescuing memory loss, neuroinflammation and beta amyloid build-up in a mouse model of Alzheimer’s disease.

An Entirely New COVID-Related Syndrome

May 9, 2024

A group of UC San Diego researchers, centered at UC San Diego’s Institute for Network Medicine, teamed up with rheumatologists at the University of Leeds in the United Kingdom to solve a medical mystery.

Study Finds Potential New Drug Therapy for Crohn’s Disease

October 17, 2012

Ustekinumab, an antibody proven to treat the skin condition psoriasis, has now shown positive results in decreasing the debilitating effects of Crohn’s Disease, according to researchers at the University of California San Diego, School of Medicine. The study will appear in the October 18, 2012 issue of the New England…

With Gene Therapy, Scientists Develop Opioid-Free Solution for Chronic Pain

March 10, 2021

A gene therapy for chronic pain could offer a safer, non-addictive alternative to opioids. By temporarily repressing a gene involved in sensing pain, the treatment increased pain tolerance in mice, lowered their sensitivity to pain and provided months of pain relief without causing numbness.

Repurposed Arthritis Drug Did Not Significantly Improve Severe COVID-19 Pneumonia

March 1, 2021

A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.

Scientists Sniff Out How the ‘Nose Knows’

May 10, 2018

…for example, in the immune system. The study was funded by grants from the Simons Foundation and the NIH, and by an NIH Fellowship. The Department of Physics’ graduate program within the Division of Physical Sciences at UC San Diego is listed among the Top 20 graduate programs by U.S.…

Genome-Wide Analysis Reveals New Strategies to Target Pancreatic Cancer

April 4, 2019

An international team of scientists led by researchers at University of California San Diego School of Medicine employed an array of next-generation sequencing and gene-editing tools, such as CRISPR, to map the molecular dependencies – and thus vulnerabilities – of pancreatic cancer stem cells.

Graduate Students Honored as Siebel Scholars

September 23, 2021

Five graduate students working at the interface of engineering and medicine have been honored as 2022 Siebel Scholars. They are pursuing graduate degrees in bioengineering, electrical engineering, nanoengineering, and bioinformatics, all with a focus on advancing human health. Five graduate student

Ultra-Thin, Flexible Probe Provides Neural Interface That’s Minimally Invasive and Long-Lasting

June 9, 2022

Researchers have developed a tiny, flexible neural probe that can be implanted for longer time periods to record and stimulate neural activity, while minimizing injury to the surrounding tissue. The probe would be ideal for studying small and dynamic areas of the nervous system like the spinal cord.

Category navigation with Social links